Full Press Release Details
Cybin to Present at the Stifel GMP 2nd Annual Future
of Healthcare Conference on December 8, 2021
TORONTO, CANADA December 1, 2021 Cybin Inc.
(NEO:CYBN) (NYSE American:CYBN) ( Cybin or the Company ), a biopharmaceutical company focused on progressing Psychedelics to
TherapeuticsTM is pleased to announce that Doug Drysdale, Cybin s Chief Executive Officer, will present at the Stifel GMP 2nd Annual
Future of Healthcare Conference being held virtually on Wednesday, December 8, 2021.
Mr. Drysdale s presentation will be webcast live on
December 8, 2021 at 3:30 p.m. ET. To listen to the event, please click here to register and access the webcast. The archived webcast will also be available on the Company s investor relations website on the Events &
leading ethical biopharmaceutical company, working with a network of world-class partners and internationally recognized scientists, on a mission to create safe and effective therapeutics for patients to address a multitude of mental health issues.
Headquartered in Canada and founded in 2019, Cybin is operational in the United States, United Kingdom and Ireland. The Company is focused on progressing Psychedelics to Therapeutics by
engineering proprietary drug discovery platforms, innovative drug delivery systems, novel formulation approaches and treatment regimens for mental health disorders.
Investor & Media Contacts:
Vice President, Investor Relations